A restriction enzyme, MspI, was introduced into cultured human cells as a probe to detect genomic regions susceptible to DNA double-strand breaks (DSBs). A 2 h exposure to MspI at a concentration of 8 U/ll produced DSBs at MspI sites in more than 80% of HeLa cells. The sensitivity to digestion was examined on chromosomal DNAs for the region containing the p16 tumor suppressor gene and two other related genes, p14ARF and p15, by Southern blot hybridization analysis and linker-mediated capture of DNA fragments digested in vivo. DNAs for the promoter regions of the three genes, respectively, were sensitive to MspI digestion in HeLa cells, while DNA for the p16 promoter region was less sensitive in lung cancer cells with hypermethylation of the region. Breakpoints for interstitial 9p21 deletions removing the p16/p14ARF/p15 locus in a variety of human cancers were significantly over-represented in the three sensitive regions. The results suggest that the MspI sensitivity in vivo of each genomic region reflects its susceptibility to DSBs that trigger chromosome aberrations in human cells. This method could help us understand the pathogenic significance of differential susceptibility to DSBs among genomic regions in human carcinogenesis.
Introduction
Chromosome aberrations, including translocations and deletions, play roles in the development of cancers by activating and inactivating oncogenes and tumor suppressor genes, respectively (Lengauer et al., 1998; Albertson et al., 2003) , and the mechanism(s) underlying their occurrence is a major issue to be elucidated for our understanding of the molecular process of human carcinogenesis. DNA double-strand breaks (DSBs) are one of the most severe types of DNA damages, and are a major factor in causing chromosomal aberrations in cells (Khanna and Jackson, 2001; van Gent et al., 2001; Obe et al., 2002; Mills et al., 2003) . The fact that several chromosome aberrations are recurrently observed and the breakpoints for some aberrations are clustered in defined regions in human cancers makes us deduce that susceptibility to DSBs is different among genomic regions, and such differences underlie the specificity and frequency of chromosome aberrations (Rabbitts, 1994; Inoue et al., 1997; Elliott and Jasin, 2002; Albertson et al., 2003; Kuwahara et al., 2004) . In fact, breakpoints for chromosome rearrangements in cultured cells, which were induced by DNA endonucleases, neutrons and g-rays, were distributed nonrandomly, and more than 60% of them were located in G-light bands preferentially consisting of uncondensed chromatins (Folle et al., 1998) . Thus, the involvement of intranuclear structures of chromatin in the specificity and frequency of chromosome aberrations has been suggested. However, it still remains unclear whether there are specific genomic regions highly susceptible to DSBs, and if there are, what unique structures of such regions are. Furthermore, the involvement of the regions in the occurrence of chromosome aberrations during carcinogenesis also remains unclear.
To elucidate the pathogenic significance of interregional differences in susceptibility to DSBs in human carcinogenesis, a restriction enzyme, MspI, was introduced into cultured human cells to probe genomic regions that are susceptible to DNA damages causing DSBs in living cells in vivo. Inter-regional differences in the sensitivity to MspI digestion were assessed by Southern blot analysis and a linker-mediated capture (LMC) method utilizing cohesive ends left by MspI digestion. Distributions of the regions sensitive to MspI digestion were compared with those of the breakpoints for chromosome deletions in cancer cells (i.e., traces of DSBs in carcinogenesis) to examine whether the MspI sensitivity reflects susceptibility to DSBs triggering chromosome aberrations in human carcinogenesis. We chose the chromosome 9p21 region containing the p16 tumor suppressor gene for this study, since this region is frequently deleted in a variety of human cancers (Kamb et al., 1994; Nobori et al., 1994; Hamada et al., 2000) , and thus, the region was thought to be a representative one suffering from DSBs in human cells. In addition, we recently mapped a number of breakpoints for the deletions in a variety of human cancers (Kitagawa et al., 2002; Sasaki et al., 2003) ; therefore, the detailed information on breakpoint locations needed for the comparison was available.
Results

Phosphorylated histone H2AX (g-H2AX) formation by restriction enzyme introduction
MspI was chosen as a restriction enzyme to be introduced due to the following reasons. First, MspI was previously introduced into living cells using an electroporation method and was indicated to be active in the cells (Winegar et al., 1990) . Second, this enzyme digests double-stranded DNA at CCGG sites (i.e., MspI sites), which are frequently present throughout the mammalian genome, being predominant at gene regions. Since the digestion is not influenced by CpG methylation, the susceptibility could be assessed preferentially for gene regions without interference by the CpG methylation status of DNA in chromatin. Third, MspI leaves cohesive ends after digestion, which enable capture of restricted DNA fragments generated by in vivo digestion, leaving DNA fragments that resulted from random sharing or DNA fragmentation due to cell death, if it occurs, during the assay.
HeLa cells were subjected to Chariot-mediated transfer of various amounts of MspI. After 2 h, induction of g-H2AX, as an indicator of DSB (Rogakou et al., 2000) , was investigated. Intranuclear g-H2AX focus formation was observed in a dose-dependent manner (Figure 1a and b) , and the effect was diminished by heat treatment of MspI. Therefore, it was suggested that transduced MspI proteins caused DSBs on chromosomal DNA, dependent on their endonuclease activity. The focus formation was observed in more than 80% of the cells when the treatment was undertaken with 4-16 U/ml of MspI, and was comparable to the one caused by ionizing radiation (IR) of 40 Gy. Dosedependent g-H2AX formation was also confirmed by Western blot analysis (Figure 1c ).
Occurrence of DSBs in vivo at MspI recognition sites
To address whether DSBs induced by MspI transduction occurred at MspI recognition sites, DNAs isolated from HeLa cells with or without (i.e., MspI storage buffer treatment) MspI treatment were completely digested with HindIII and subjected to Southern blot analysis of the promoter region of the p16 gene. A DNA probe, 228B (Figure 2A) , recognized a single band of 5.6 kb against DNA obtained from HeLa cells without MspI treatment, while it recognized additional bands of approximately 1.7-2.0 kb against DNA obtained from HeLa cells with MspI treatment (Figure 2Bb) . A band of 0.5 kb, which corresponds to the HindIII-MspI fragment containing the probe site (see lane 'in vitro' in Figure 2Bb ), was not observed in these samples. This result suggested that MspI sites, M3-M8, located in the p16 promoter region, but not the M1 and M2 sites, were subjected to MspI digestion. To exclude the possibility that the digestion observed above occurred during the DNA isolation procedure, HeLa cells were also exposed to MspI without the Chariot reagent. No band corresponding to the DNA fragment generated by MspI digestion was visible (data not shown); thus, it was indicated that this method caused MspI digestion of chromosomal DNA in living cells.
To further confirm that MspI sites in the p16 promoter region were digested by MspI in vivo, linkermediated PCR (LMPCR) was performed ( Figure 2A ). DNAs from HeLa cells with or without MspI treatment at 8 U/ml were ligated with a linker after primer extension using primer-1 or -2, which are both located in the p16 promoter region, and amplified with a linker primer and nested primers. PCR products with sizes corresponding to those of DNA fragments cleaved at MspI sites, M5 and M6, and M7 and M8, in the promoter region, were detected in MspI-treated cells, but not in the buffer-treated cells ( Figure 2C ). The results supported the fact that MspI sites in the p16 promoter region were subjected to MspI digestion in vivo.
Differential sensitivity to digestion among MspI sites
Sensitivity to MspI digestion was examined among several MspI sites in a 60 kb region containing the p16 and two other related genes, p14ARF and p15 ( Figure 3A ). HeLa and H1299 cells were treated with or without 8 U/ml MspI, and the sensitivity to MspI digestion was assessed in four regions, promoters for the p16, p14ARF and p15 genes and intron 2 shared by the p16 and p14ARF genes ( Figure 3B and C). A probe, 265A, detected a major band of 1.8 kb in both HeLa and H1299 cells, while a probe 248A detected a few bands of 1.5-3.0 kb in both cells (Figure 3Ba and b) . These results indicate that MspI sites in the promoter regions of the p15 and p14ARF genes were digested. The fact that approximately 20 and 35% of the fragments were digested in HeLa and H1299 cells, respectively, indicates that considerable fractions of chromosomal DNAs for the regions were subjected to digestion in these cells ( Figure 3C ). Both the p15 and p14ARF genes are expressed in HeLa and H1299 cells ( Figure 3D ). In contrast, a probe, 218B, did not detect any digested bands either in HeLa and H1299 cells treated with MspI (Figure 3Bd ), indicating that chromosomal DNA for this region was refractory to digestion in both cell lines.
In contrast to the above results, a differential sensitivity to digestion was observed at the p16 promoter region between HeLa and H1299 cells. p16 expression is silenced in H1299 cells due to hypermethylation of the promoter region (Sato et al., 2002) , while p16 is expressed in HeLa cells. As mentioned above, the 228B probe detected a major band of 1.7-2.0 kb in HeLa cells treated with MspI. In H1299 cells, however, the probe detected at least five bands ranging from 1.7 to 4.0 kb (Figure 3Bc ). The fraction of DNA digested in H1299 cells was considerably lower in this region than in promoter regions of p14ARF and p15, while similar fractions of DNA were digested at all three promoter regions in HeLa cells ( Figure 3C ). The results indicated that MspI sensitivity in vivo is influenced by chromatin configuration associated with the status of DNA methylation.
MspI sensitivity in vivo along the genome
To evaluate the relative sensitivity to MspI digestion along the genome at a higher resolution, we developed a PCR-based quantification method. The method is illustrated in Figure 4 . Briefly, MspI ends generated in vivo were ligated with a biotinylated linker containing an end cohesive with the MspI end ( Figure 4a ). The ligated sites were designed to be refractory to MspI digestion. Next, ligated DNA solution was subjected to MspI digestion to cleave MspI sites uncleaved in vivo ( Figure 4b ). By using streptavidin beads, MspI fragments with at least one MspI site cleaved in vivo were purified. These DNA fragments were then released from the beads by BamHI digestion within the linker, and used as a template for real-time quantitative PCR. The susceptibility to digestion of each MspI segment (i.e., a segment between two adjacent MspI sites) was expressed as a fraction of captured DNA among input DNA (sensitivity score in Figure 5a and b). We designated this method as LMC. The LMC assay was applied to MspI segments in the 60 kb region containing the p16, p14ARF and p15 genes in HeLa cells, and the sensitivity scores were calculated at 30 MspI segments ( Figure 5a ). When genomic DNAs obtained from HeLa cells with or without MspI treatment at 8 U/ml were subjected to LMC, three obvious peaks of sensitivity scores were observed in the 60 kb region only in MspI-treated cells. Sensitivity scores of the region upstream of the p16 and p15 promoter and the intron 2 region of the p16/p14ARF gene were considerably lower than those of three promoter regions. Seven MspI segments, which were found refractory to digestion in vivo by Southern blot hybridization analysis, showed considerably lower sensitivity scores than segments in the promoter regions (indicated by asterisks in Figure 5a) ; thus, the results were compatible with those of Southern blot hybridization analysis (Figure 3b ). Sensitivity scores were also calculated for the locus of a housekeeping gene, GAPDH ( Figure 5b ). All the three sites examined were found sensitive to MspI, while its promoter region was indicated to be more sensitive than the other regions.
Comparison between the regions sensitive to MspI digestion in vivo and locations of breakpoints for interstitial deletions in human cancers on chromosome 9p21
We previously mapped breakpoints for the interstitial 9p21 deletions removing the p16/p14ARF/p15 locus in a variety of human cancers (Kitagawa et al., 2002; Sasaki et al., 2003) . To examine whether or not the chromosomal DNAs sensitive to MspI digestion are susceptible to DSBs during human carcinogenesis, these breakpoints were mapped on the MspI sensitivity map (Figure 5a ). In total, 55 breakpoints, consisting of 17 breakpoints in lymphoid leukemia and 38 breakpoints in various other types of cancers (nonhematological malignancies), were mapped in the 60 kb region, where the sensitivity to MspI digestion in vivo was estimated.
We first divided the 30 MspI segments into 'sensitive' and 'nonsensitive' ones by a threshold sensitivity score of 0.56 Â 10
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, which was the value of the mean þ 3 standard deviation (s.d.) among MspI sensitivity scores for the seven segments refractory to MspI digestion described above. A region consisting of sensitive segments and unexamined regions flanked by the sensitive segments were defined as the 'sensitive' regions, and there were three such regions. The regions included promoters of the p16, p14ARF and p15 genes, respectively (regions shaded in Figure 5a ). The sensitive regions covered 24% of the 60 kb region. The regions consisting of nonsensitive segments and unexamined regions flanked by the nonsensitive segments were defined as the 'nonsensitive' region and covered 72%. The regions between a sensitive and a nonsensitive segment were defined as the 'ambiguous' region and covered the remaining 4%.
We then assessed whether the breakpoints for interstitial 9p21 deletions were over-represented in the sensitive regions for MspI digestion in vivo. Our previous studies indicated that DSBs triggering deletions in lymphoid leukemia are produced by the RAG complex, a DNA endonuclease used for V(D)J recombination, while those in other cancers are produced at unspecific sites by as yet unidentified factors (Kitagawa et al., 2002; Sasaki et al., 2003) . Thus, the distributions were analysed not only in total but also after dividing into lymphoid leukemia and other cancers. The number of breakpoints mapped in the sensitive regions was significantly larger than predicted in total, in lymphoid leukemia and in other cancers (Table 1 ). In particular, 16 (94%) breakpoints in lymphoid leukemia including 11 in the breakpoint cluster sites (BCSs), BCS-LL3 and -LL2 (Kitagawa et al., 2002) , were mapped in the sensitive regions. A 10 kb region, where the largest number of the breakpoints in other cancers was mapped ('200-210 kb region' in Sasaki et al., 2003) , was overlapped with an MspI-sensitive region including the p16 promoter region.
Discussion
In the present study, we introduced a restriction enzyme, MspI, into human living cells using Chariot reagent, and assessed the activity of MspI to produce DSBs in chromosomal DNA in vivo. g-H2AX induction indicated that DSBs were generated in more than 80% of HeLa cells within 2 h of exposure to 4-16 U/ml of MspI. The induction levels were comparable to the one caused by IR of 40 Gy, which was estimated to cause 1600 DSBs per cell (i.e., 40 DSBs/Gy/cell) (Moiseenko et al., 1998) . Thus, more than 1600 DSBs were considered to be generated per cell into which MspI was introduced. Southern blot hybridization and LMPCR analyses indicated that DSBs were generated at MspI recognition sites. In addition, genomic DNAs from the cells with an RT-PCR was performed as described previously (Xing et al., 1999; Park et al., 2003) Chromosome 9p21 region susceptible to DNA DSBs M Sato et al exposure at 8 U/ml did not show significant DNA degradation or ladder formation ( Figure 2Ba) ; therefore, DSBs were likely to be formed mostly by specific digestion at MspI sites of chromosomal DNA but not by DNA fragmentation in apoptosis or DNA degradation at unspecific sites. In this study, MspI was used as a representative restriction enzyme to be introduced; however, another enzyme, HaeIII, was also functional (data not shown). Therefore, it was indicated that several restriction enzymes can be used to induce DSBs in living cells. Introduction of DNase I into HeLa cells was also undertaken; however, the enzyme was considerably less functional in inducing DSBs in HeLa cells than MspI or HaeIII (data not shown). This might be due to the fact that actin, a major cellular protein in mammalian cells, works as an inhibitor of DNase I (Lazarides and Lindberg, 1974) .
In the present study, we also demonstrated that the sensitivity to MspI digestion is different among genomic regions. By using the LMC method, we constructed an MspI sensitivity map of a 60 kb region at chromosome 9p21 covering the p16 gene locus in HeLa cells. Chromosomal DNAs for the promoter regions of the p16, p14ARF and p15 genes were found more sensitive to MspI digestion in vivo than those for other regions. It was also suggested that the sensitivity of these regions was similar to that of a housekeeping gene locus, GAPDH. The copy number of GAPDH transcripts in human cells was indicated to be more than one hundred times higher than those of p16, p14ARF or p15 transcripts (http://cgap.nci.nih.gov/SAGE). Thus, the sensitivity may not directly correlate with the level of transcription. Chromosomal DNA for the p16 promoter region was less sensitive to MspI digestion in cells with hypermethylation of the region (Figure 3) . It has been indicated that gene promoter regions take loose configurations of chromatin; however, their hypermethylation in cells is associated with condensation of chromatin (Nguyen et al., 2001 ). Thus, a loose configuration of chromatin could make MspI more accessible to DNA than a condensed one, as indicated by studies on the endonuclease sensitivity to chromatin DNA in isolated nuclei (Gross and Garrard, 1988; Antequera et al., 1990; Costello et al., 1996) . Alternatively, the accessibility of MspI could be similar among chromatins, but DNAs in looser chromatins could have a higher chance to be attacked by MspI, since loose chromatins have a lower DNA content per unit volume in nuclei than condensed chromatins (Obe et al., 2002) . Further studies are needed to clarify the molecular basis for MspI sensitivity in vivo.
Distribution of MspI-sensitive regions in HeLa cells and that of 55 breakpoints for interstitial 9p21 deletions in a variety of human cancers were compared. The promoter regions of the p16, p14ARF and p15 genes are free from methylation in HeLa cells, as in human noncancerous cells, and gross rearrangements and mutations for the three genes have not been reported. Therefore, we used HeLa as a reference cell for MspI sensitivity in vivo. Breakpoints were significantly overrepresented in MspI-sensitive regions; therefore, the sensitivity to MspI digestion in vivo was suggested to reflect the susceptibility to DSBs that trigger chromosome aberrations in human carcinogenesis.
In previous studies, breakpoints for interstitial 9p21 deletions in lymphoid leukemia were found clustered at a few defined sites (i.e., BCSs) that have nucleotide sequences similar to recombination signal sequences (RSSs) for V(D)J recombination (Cayuela et al., 1997; Kitagawa et al., 2002; Raschke et al., 2005) . The results indicated that DSBs were illegitimately produced by the RAG complex. However, a number of sites with RSSlike sequence were present in or near the p16 locus; thus, it was also suggested that BCSs have an unknown feature(s) that enhances DSBs by RAG proteins other than the similarity in nucleotide sequences to RSS (Kitagawa et al., 2002) . In this study, breakpoints of lymphoid leukemia were exclusively mapped in MspIsensitive regions. Therefore, the chromatin for the BCSs was thought to take a configuration(s) making them susceptible to digestion by DNA endonucleases such as restriction enzymes and RAG proteins. Breakpoints for 9p21 deletions in nonhematological malignancies were not mapped at specific DNA sequences (Florl and Schulz, 2003; Sasaki et al., 2003; Raschke et al., 2005) . Therefore, genomic features enhancing DSBs were unclear. In the present study, breakpoints for 9p21 deletions were preferentially mapped at MspI-sensitive regions, although the tendency was less clear than that in lymphoid leukemia. Thus, breakpoints in nonhematological malignancies are also likely to be located in chromosomal DNA, taking an architecture susceptible to DSBs by DNA-damaging agents. The present study focused on the p16 region as a representative region suffering from DSBs, and the results indicated that MspI sensitivity in vivo might be useful as a marker to detect genomic regions susceptible to DSBs. At present, the architecture making the genome more susceptible to DSBs is unclear. As described above, the loose configuration of chromatin (i.e., 'open' chromatin structure) might be a cause of the susceptibility to DSBs. However, it is not yet clear why open chromatin regions break. There might be some Figure 3a and b. Gray shading indicates the MspI-sensitive regions (see text). A total of 55 breakpoints for the interstitial deletions of the p16/p14ARF/p15 locus in human cancers are shown by arrowheads. Breakpoints within a 500 bp interval of each other are shown at the same position. The color code indicates the cancer type as follows: lymphoid leukemia (black), lung cancer (red), melanoma (light-blue), esophageal cancer (green), breast cancer (orange), renal cell carcinoma (purple), head and neck cancer (blue), glioma (pink), osteosarcoma (brown), pancreas cancer (yellow) and ovarian cancer (gray). BCS-LL3 and -LL2, breakpoint cluster sites in lymphoid leukemia (Kitagawa et al., 2002) , and 10 kb BCR, a 10 kb region where the largest number of the breakpoints in solid tumors were mapped (Sasaki et al., 2003) , are indicated. (b) The MspI sensitivity map of the GAPDH gene region. Indications are the same as in panel a 
À9
. P-values are from an exact binomial test
Chromosome 9p21 region susceptible to DNA DSBs M Sato et al unique features underlying the susceptibility in such regions. Thus, the architecture susceptible to DSBs is to be further investigated. Analyses of other chromosomal regions and cells will further elucidate the relationship between MspI sensitivity and susceptibility to DSBs triggering chromosome aberrations and also help understanding of the architecture susceptible to DSBs. DSBs triggering translocations of the MLL gene at chromosome 11q23 in human leukemia are considered as being caused by DNA replication blocks caused by anticancer drugs, such as DNA topoisomerase II inhibitors, and/or by DNA nuclease reaction in apoptosis (Broeker et al., 1996; Rowley, 2001; Elliott and Jasin, 2002; Daser and Rabbitts, 2004) . Interestingly, the involvement of intranuclear chromatin architecture of the MLL region, including its association with the nuclear matrix and its loose chromatin configuration, in the locations of breakpoints has been suggested (Broeker et al., 1996; Strissel et al., 1998; Sim and Liu, 2001; Stanulla et al., 2001; Khobta et al., 2004) . Therefore, the MLL locus will also be a region worth examining for MspI susceptibility.
Materials and methods
Cell culture
HeLa cells were grown in Dulbecco's modified Eagle's medium with 10% fetal bovine serum (FBS) and antibiotics (penicillin and streptomycin), and H1299 cells were grown in RPMI medium 1640 with 10% FBS and antibiotics. Both cells were maintained in an atmosphere of 5% CO 2 at 371C.
Chariot-mediated restriction enzyme transduction
Cells were grown on a 12-well plate, six-well plate or a 60-mmdiameter dish to 80% confluence. Restriction enzymes were introduced into cultured cells by Chariot reagent according to the manufacturer's instructions (Active Motif, Carlsbad, CA, USA). To treat the cells with 0, 2, 4 and 8 U/ml of MspI (100 000 U/ml) (NEB, Beverly, MA, USA) in a 60-mmdiameter dish, respectively, 200 ml of MspI solution containing 0, 2500, 5000 and 10 000 U of MspI diluted with phosphatebuffered saline (PBS) and 200 ml of Chariot solution containing 0, 30, 60 and 120 ml of Chariot agent diluted with water were mixed, and incubated for 30 min at room temperature. After washing the cells once with PBS, the mixtures were added to the dishes followed by an addition of 800 ml of serum-free medium (i.e., the final volume was 1200 ml). After incubation for 1 h, 2 ml of complete medium was added. At 1 h after addition, cells were subjected to genomic DNA isolation, immunofluorescence staining and Western blotting. When the cells in 12-and six-well plates were treated, the final volume for treatment in each well was reduced to 250 and 600 ml, respectively. Detailed protocols can be obtained upon request.
Immunofluorescence analysis
Cells grown on a coverslip were fixed in 4% paraformaldehyde and permeabilized in 0.2% Triton X-100 for 10 min. After blocking treatment, the cells were incubated with 1 : 1000 of anti-g-H2AX monoclonal antibody (Upstate, Charlottesville, VA, USA) for 1 h, followed by incubation with 1 : 1000 of 
Western blot hybridization analysis
Cell pellets were subjected to acid extraction according to an Upstate instruction manual. Western blot hybridization was performed with 1 : 1000 of anti-g-H2AX monoclonal antibody (Upstate) and 1 : 200 of anti-H2A rabbit polyclonal antibody (H-124) (Santa Cruz, Santa Cruz, CA, USA) for rehybridization as described previously (Furuta et al., 2003) .
Genomic DNA isolation
Cells with or without (i.e., MspI storage buffer treatment) treatment with MspI in a 60-mm-diameter dish were washed twice with cold PBS containing 2.5 mM EDTA. MspI activity was quenched by adding a lysis solution (100 mM NaCl, 50 mM EDTA, pH 8.0, 1% SDS, 200 mg/ml of proteinase K) to the culture dish, and the lysate was incubated at 551C overnight. The lysate was subjected to two rounds of phenol/chloroform extraction with a ribonuclease A treatment between them. Genomic DNA was precipitated with 0.7 volumes of isopropanol, collected by centrifugation at 41C at 17 000 g for 30 min, rinsed with 70% ethanol and resuspended in TE buffer.
Southern blot hybridization analysis
A 10 mg portion of genomic DNAs was digested with HindIII, and subjected to electrophoresis through a 1.2% agarose gel. After acid treatment, the gel was transferred to a nylon membrane by alkali blotting. The membrane was hybridized with DNA probes and washed according to the standard procedure. The hybridization signal was analysed by a BAS 2500 imaging analyzer (Fuji Film, Tokyo, Japan). DNA fragments used for probes were prepared by PCR against human genomic DNA using primer sets (Table 2) , and were labeled with the Prime-It II random primer labeling kit (Stratagene, La Jolla, CA, USA).
Linker-mediated PCR LMPCR was performed as described previously (Costello et al., 1996) with some modifications. Briefly, 5 mg of genomic DNAs, which were quantified by a Picogreen dsDNA Quantitation Kit (Molecular Probes), was used for each sample. After heat denaturing, DNA was subjected to a round of gene-specific primer extension to generate DNA fragments with blunt ends at cleaved sites using a primer, primer-1 or primer-2, and the fragments were ligated to a blunt-end linker. A one-fifth aliquot was subjected to PCR of 28 cycles using a linker primer, linker-1, and a nested gene-specific primer, primer-1N or primer-2N. PCR products were labeled by two additional cycles of PCR using the linker-1 primer and a FAM-labeled nested primer, primer-1-FAM, or a HEXlabeled nested primer, primer-2-HEX. To standardize the amounts of substrates used for LMPCR, a one-fifth aliquot was also subjected to PCR of 18 cycles using a set of primers (p16-25943F-NED and p16-26072R) that amplify a DNA fragment in intron 2 of the p16 gene in multiplex PCR. PCR products were electrophoresed and analysed by an ABI 310 genetic analyzer (Applied Biosystems, Foster City, CA, USA). Sequences for PCR primers used are described in Table 2 .
Linker-mediated capture of the MspI-sensitive fragments and their quantification
MspI transduction and the following LMC were undertaken in triplicate. A 10 mg portion of genomic DNA isolated from cells with or without exposure to MspI was dissolved in 100 ml of LoTE (3 mM Tris-HCl, pH 7.5, 0.2 mM EDTA, pH 7.5). A 90 ml volume of the DNA was subjected to LMC, while another 9 ml was diluted in 200 ml of TE buffer and used to estimate the amounts of 'input DNA' by quantitative PCR. In LMC, 100 pmol of a biotinylated LMC linker was ligated with genomic DNAs in 100 ml of T4 ligase buffer with 4000 U of T4 ligase (NEB) overnight at 161C. After heat inactivation of T4 ligase, 10 ml of 10Â NEB2 buffer was added and DNAs were digested with 200 U of MspI for 6 h at 371C. The DNA solution was mixed with 100 ml of streptavidin magnetic beads M-280 (Dynal Biotech, Oslo, Norway), which had been blocked with 100 mg of sonicated salmon sperm DNA, in 400 ml of 1 Â binding buffer (Dynal Biotech) for 3 h with rotation. After washing five times with 500 ml of washing buffer (5 mM Tris-HCl, pH 7.5, 0.5 mM EDTA, 1.0 M NaCl, 1 mg/ml BSA), the beads were subjected to MspI digestion again with 200 U of MspI for 3 h at 371C with rotation. After washing five times as described above, MspI fragments captured by the beads were released by digestion with BamHI (180 U) for 6 h at 371C with rotation. The supernatant was concentrated by Microcon YM-30 and Microcon EZ (Millipore, Billerica, MA, USA), diluted in 200 ml TE buffer, and used as 'captured DNA' solution. A total of 33 primer pairs designed to specifically amplify DNA fragments of 90-200 bp in size were set for 30 and three MspI fragments in the regions containing the p16 and GAPDH genes, respectively. Sequences for the primer sets are described in Table 2 . Captured DNAs in triplicate and the corresponding input DNAs were quantified for each MspI fragment by quantitative PCR, and the fraction of captured DNA among input DNA for each fragment was expressed as an average7s.d. Quantitative real-time PCR was performed on an ABI 7900HT (Applied Biosystems) using Quantitect SYBR Green PCR kits (Qiagen, Valencia, CA, USA) in duplicate, and dissociation curve analysis was performed for each amplicon.
Statistical analysis
An exact binomial test was performed on the website, http:// faculty.vassar.edu/lowry/binomialX.html, on the hypothesis that the proportion of breakpoints mapped in MspI-sensitive regions is equal to 0.254 of the total breakpoints, since the proportion of breakpoints mapped in MspI-sensitive regions among MspI-sensitive and -nonsensitive regions was deduced to be 0.254 ( ¼ 14 859/58 415). P-values of less than 0.05 were considered as being statistically significant. Abbreviations DSB, double-strand break; IR, ionizing radiation; LMPCR, linker-mediated PCR; LMC, linker-mediated capture; BCSs, breakpoint cluster sites; RSSs, recombination signal sequences; PBS, phosphate-buffered saline.
